Table 2.
Univariable logistic regression analysis identifies female sex and older age as predictors for hematotoxicity. Abbreviations: OR, odds ratio; CI, confidence interval; PPI, proton pump inhibitior treatment
| Pooled | Lomustine-Temozolomide | Temozolomide | |||||||
|---|---|---|---|---|---|---|---|---|---|
| OR | 95% CI | P | OR | 95% CI | p | OR | 95% CI | p | |
| Female sex | 2.47 | 1.00–6.10 | 0.050 | 3.15 | 0.87–11.48 | 0.08 | 2.08 | 0.56–7.79 | 0.28 |
| Age | 1.08 | 1.02–1.15 | 0.011 | 1.09 | 0.99–1.19 | 0.06 | 1.08 | 0.99–1.18 | 0.09 |
| Creatinine > 1 mg/dl | 0.21 | 0.02–1.64 | 0.14 | 0.35 | 0.04–2.99 | 0.35 | 0.00 | 0–0 | 0.99 |
| Platelets < 270/µl | 0.37 | 0.27–1.62 | 0.37 | 0.77 | 0.22–2.69 | 0.68 | 0.56 | 0.15–2.11 | 0.39 |
| PPI | 0.69 | 0.24–2.02 | 0.50 | 0.67 | 0.14–3.64 | 0.67 | 0.58 | 0.16–2.79 | 0.67 |
| Steroid treatment at baseline | 1.01 | 0.26–3.87 | 0.99 | 2.5 | 0.40–15.56 | 0.33 | 0.42 | 0.48–3.72 | 0.44 |
| Experimental arm | 0.94 | 0.39–2.29 | 0.90 | – | – | – | – | – | – |
OR odds ratio, CI confidence interval, PPI proton pump inhibitior treatment